• Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China;
Lu Hai, Email: trdr_luhai@163.com
Export PDF Favorites Scan Get Citation

Open ocular trauma in children is one of the main causes of non-congenital monocular blindness in children. Children’s psychological and daily activities are different from those of adults; the eye tissue structure is not maturely enough, and the characteristics of high response to injury and incompatibility with various diagnostic and treatment methods determine the factors that cause injuries and injuries in children with open ocular trauma. The environment, diagnosis and treatment, and prognosis of children are more complicated than adults. For the emergency of first and second stage on diagnosis and treatment of children with open ocular trauma, it should follow the principles of adult open ocular trauma management, combined with the children's characteristics, clarifying the anatomical location of the ocular trauma before surgery, and closing the wound during the first-stage operation. At the same time, the disturbance of intraocular tissue should be minimized, the timing of the second stage operation and the individualization of the operation design, and the medication and care after the operation should also be combined with the characteristics of children. Prevention of ocular trauma in children is the focus of attention. In the new information era, clinical research and public information platforms should be fully utilized to advance the epidemiological study of children's ocular trauma and guide the construction of the prevention and treatment system for children's ocular trauma more scientifically.

Citation: Lu Hai, Liu Jinghua. Correctly understanding the complexity of diagnosis and treatment of children's open ocular trauma to improve its diagnosis and treatment effect. Chinese Journal of Ocular Fundus Diseases, 2021, 37(5): 333-337. doi: 10.3760/cma.j.cn511434-20210512-00250 Copy

  • Next Article

    Individual dose of intravitreal conbercept for efficacy in retinopathy of prematurity